Associated Papers
RET signaling pathway and RET inhibitors in human cancer.
Regua AT et al.
Frontiers in Oncology, 2022
Comprehensive assessment of the disputed RET Y791F variant shows no association with medullary thyroid carcinoma susceptibility.
Toledo RA et al.
Endocrine-related Cancer, 2015
25425582 (PubMed )
Supplement: supp_ERC-14-0491_Supplementary_table_2.xlsx › Sheet1
Select a paper to view details